Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

$35 million more for device center

This article was originally published in The Silver Sheet

Executive Summary

CDRH would receive a $35 million increase for center and field activities under a fiscal year 2010 funding measure approved June 11 by the House Agriculture, Rural Development, FDA and Related Agencies Appropriations Subcommittee. This accords with the 12.5 percent increase over FY 2009 funding that President Obama requested for the device center in his FY 2010 budget proposal to Congress ("The Silver Sheet" May 2009). Subcommittee Chairwoman Rosa DeLauro, D-Conn., says the investment will "help reform and significantly improve" how FDA ensures medical product safety. The funding boost would bring appropriations for CDRH to $315 million in FY 2010; user fees from industry would provide an additional $56 million to the center's budget. Overall, the subcommittee approved $2.35 billion for FDA for the next fiscal year - an increase of $298.6 million above FY 2009 funding levels
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT036359

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel